--News Direct--
Our recent survey conducted with Harris Poll and Depression and Bipolar Support Alliance found that many individuals with Bipolar 1 disorder felt that finding the right treatment can be a long and difficult process.
About Alkermes Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com .
View additional multimedia and more ESG storytelling from Alkermes on 3blmedia.com
View source version on newsdirect.com: https://newsdirect.com/news/for-individuals-with-bipolar-1-disorder-finding-the-right-treatment-can-be-a-long-and-difficult-process-787900292